Pilar Nos

5.5k total citations
175 papers, 3.0k citations indexed

About

Pilar Nos is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Pilar Nos has authored 175 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Genetics, 99 papers in Epidemiology and 72 papers in Surgery. Recurrent topics in Pilar Nos's work include Inflammatory Bowel Disease (132 papers), Microscopic Colitis (90 papers) and Eosinophilic Esophagitis (29 papers). Pilar Nos is often cited by papers focused on Inflammatory Bowel Disease (132 papers), Microscopic Colitis (90 papers) and Eosinophilic Esophagitis (29 papers). Pilar Nos collaborates with scholars based in Spain, United States and Chile. Pilar Nos's co-authors include Belén Beltrán, Marisa Iborra, Guillermo Bastida, Mariam Aguas, Julio Ponce, Inés Moret, Elena Cerrillo, Eugeni Domènech, Joaquín Hinojosa and Javier P. Gisbert and has published in prestigious journals such as Gastroenterology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Pilar Nos

164 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pilar Nos Spain 29 1.6k 1.3k 849 567 423 175 3.0k
Jason K. Hou United States 24 1.4k 0.8× 1.0k 0.8× 808 1.0× 611 1.1× 239 0.6× 116 2.8k
Lene Riis Denmark 31 2.0k 1.2× 1.6k 1.3× 1.0k 1.2× 506 0.9× 576 1.4× 90 3.3k
Pieter Hindryckx Belgium 28 2.1k 1.3× 1.5k 1.2× 1.1k 1.3× 658 1.2× 535 1.3× 88 3.5k
Marcus Harbord United Kingdom 15 2.2k 1.3× 1.6k 1.3× 843 1.0× 392 0.7× 637 1.5× 26 3.0k
Kim L. Isaacs United States 29 2.3k 1.4× 1.5k 1.2× 1.3k 1.5× 521 0.9× 654 1.5× 95 3.9k
Glen Doherty Ireland 32 1.5k 0.9× 1.1k 0.9× 804 0.9× 735 1.3× 782 1.8× 148 3.5k
Mollie Ferris Canada 4 2.5k 1.5× 1.7k 1.4× 1.4k 1.7× 785 1.4× 678 1.6× 7 4.1k
Greg Chernoff United States 5 2.5k 1.5× 1.7k 1.3× 1.4k 1.6× 794 1.4× 679 1.6× 9 4.1k
Ing Shian Soon Canada 8 2.7k 1.6× 1.8k 1.4× 1.3k 1.5× 807 1.4× 733 1.7× 15 4.1k
Nicholas A. Kennedy United Kingdom 30 1.6k 1.0× 877 0.7× 785 0.9× 1.5k 2.6× 688 1.6× 160 3.8k

Countries citing papers authored by Pilar Nos

Since Specialization
Citations

This map shows the geographic impact of Pilar Nos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pilar Nos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pilar Nos more than expected).

Fields of papers citing papers by Pilar Nos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pilar Nos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pilar Nos. The network helps show where Pilar Nos may publish in the future.

Co-authorship network of co-authors of Pilar Nos

This figure shows the co-authorship network connecting the top 25 collaborators of Pilar Nos. A scholar is included among the top collaborators of Pilar Nos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pilar Nos. Pilar Nos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Núñez, Paulina, et al.. (2024). Personalised therapy in inflammatory bowel disease. Gastroenterología y Hepatología (English Edition). 47(7). 763–770. 2 indexed citations
3.
Almela, Pedro, et al.. (2024). Leishmania infection in patients with inflammatory bowel disease: Case series and literature review. Gastroenterología y Hepatología (English Edition). 47(1). 82–92.
4.
Nos, Pilar, et al.. (2024). Association of Smoking and Crohn's Disease: An Update. 6(3). 140–147.
5.
Val, A. del, et al.. (2023). Predictive model of persistent choledocholithiasis in patients with acute biliary pancreatitis. Gastroenterología y Hepatología (English Edition). 46(4). 297–304. 1 indexed citations
6.
Bastida, Guillermo, et al.. (2023). Evaluation of tolerance to mercaptopurine in patients with inflammatory bowel disease and gastrointestinal intolerance to azathioprine. Gastroenterología y Hepatología. 47(5). 473–480. 1 indexed citations
7.
8.
Bastida, Guillermo, Mariam Aguas, Manuel Barreiro‐de Acosta, et al.. (2023). The Risk of Developing Disabling Crohn’s Disease: Validation of a Clinical Prediction Rule to Improve Treatment Decision Making. Digestive Diseases. 41(6). 879–889. 3 indexed citations
9.
10.
Iborra, Marisa, Guillermo Bastida, Mariam Aguas, et al.. (2022). P383 Ustekinumab as an opportunity for refractory Ulcerative Colitis patients. Journal of Crohn s and Colitis. 16(Supplement_1). i383–i384. 5 indexed citations
11.
Sáez‐González, Esteban, Inés Moret, Marisa Iborra, et al.. (2021). Oxidative Stress in the Pathogenesis of Crohn’s Disease and the Interconnection with Immunological Response, Microbiota, External Environmental Factors, and Epigenetics. Antioxidants. 10(1). 64–64. 78 indexed citations
12.
Paredes, Ana García García de, Enrique Rodríguez de Santiago, Marisa Iborra, et al.. (2020). Idiopathic acute pancreatitis in patients with inflammatory bowel disease: A multicenter cohort study. Pancreatology. 20(3). 331–337. 14 indexed citations
13.
Boscá-Watts, Marta Maia, Rafael Alós, Nuria Maroto, et al.. (2020). Recommendations of the Crohn’s Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn’s disease. Gastroenterología y Hepatología (English Edition). 43(3). 155–168. 8 indexed citations
14.
Zabana, Yamile, Julián Panés, Pilar Nos, et al.. (2020). The ENEIDA registry (Nationwide study on genetic and environmental determinants of inflammatory bowel disease) by GETECCU: Design, monitoring and functions. Gastroenterología y Hepatología (English Edition). 43(9). 551–558. 7 indexed citations
15.
Hoyo, Javier del, Pilar Nos, Raquel Faubel, et al.. (2020). Adaptation of TECCU App Based on Patients´ Perceptions for the Telemonitoring of Inflammatory Bowel Disease: A Qualitative Study Using Focus Groups. International Journal of Environmental Research and Public Health. 17(6). 1871–1871. 7 indexed citations
16.
López–Sanromán, Antonio, Joan Clofent, Esther García-Planella, et al.. (2018). Reviewing the therapeutic role of budesonide in Crohn's disease. Gastroenterología y Hepatología (English Edition). 41(7). 458–471. 8 indexed citations
17.
Iborra, Marisa, Belén Beltrán, Nuria Maroto, et al.. (2018). Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents. Gastroenterología y Hepatología (English Edition). 41(9). 535–543. 1 indexed citations
18.
Aguas, Mariam, Javier del Hoyo, Raquel Faubel, et al.. (2018). A Web-Based Telemanagement System for Patients With Complex Inflammatory Bowel Disease: Protocol for a Randomized Controlled Clinical Trial. JMIR Research Protocols. 7(12). e190–e190. 6 indexed citations
19.
Taxonera, Carlos, et al.. (2016). P603. Response and remission rates with up to 3 years of vedolizumab treatment in patients with Crohn’s disease. Journal of Crohn s and Colitis. 10(suppl 1). S406.2–S407.
20.
Iborra, Marisa, Belén Navarro, Xavier Cortés, et al.. (2016). P459. Risk of relapse after azathioprine discontinuation in inflammatory bowel disease patients in maintained remission. Journal of Crohn s and Colitis. 10(suppl 1). S333–S334. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason K. Hou Breakdown of academic impact, for papers by Lene Riis Breakdown of academic impact, for papers by Pieter Hindryckx Breakdown of academic impact, for papers by Marcus Harbord Breakdown of academic impact, for papers by Kim L. Isaacs Breakdown of academic impact, for papers by Glen Doherty Breakdown of academic impact, for papers by Mollie Ferris Breakdown of academic impact, for papers by Greg Chernoff Breakdown of academic impact, for papers by Ing Shian Soon Breakdown of academic impact, for papers by Nicholas A. Kennedy
Rankless by CCL
2026